Equity Briefing: AMRI Second Quarter Earnings Correction

Last week, Equity Briefing incorrectly reported that Albany Molecular Research
(NASDAQ: AMRI) reported $0.01 earnings per share for the second quarter. Albany
Molecular Research's actual earnings were $0.06 per share for the second
quarter, beating the Thomson Reuters Consensus estimate of $0.02 by $.04.



This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Equity Briefing via Thomson Reuters ONE
[HUG#1632490]